IMU 5.56% 5.7¢ imugene limited

Ann: Next cohort reached in IV arms of CF33-hNIS (VAXINIA) study, page-85

  1. 1,887 Posts.
    lightbulb Created with Sketch. 358
    imugene may fail as a company.
    it may not.

    thats the business of investing.
    it could trade at 5c or 3c tomorrow but it wont mean imugene is a success or failure.

    there is one main reason any investor would park some funds in Imugene and aim to check back in 6, 12, 24 months time,

    CF33.

    5 trials at least are ongoing right now to test the hypothesis that cf33 is the next new platform to treat cancer.

    IF successful enough , one of the range of outcomes is that it will replace many of the existing , harsh and ineffective options that currently exist.

    imugene will sell out for billions.

    the upside is 10x minimum from here.

    imugene is at the point where the risk reward makes a lot of sense.

    yuman fong , cancer killing genius , has a ring to it.

    once the equity rallies gather more steam over the next few months no doubt some of these bios have a lot of room to run

    gltah , may the patience be rewarded
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.7¢
Change
0.003(5.56%)
Mkt cap ! $417.2M
Open High Low Value Volume
5.5¢ 5.8¢ 5.2¢ $2.499M 45.00M

Buyers (Bids)

No. Vol. Price($)
2 1921794 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 1368288 7
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.